Investor Relations
Mylan Laboratories Inc. is a leading pharmaceutical company with four subsidiaries,
Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc.
that develop, manufacture and market an extensive line of generic and proprietary products.
Latest News
| 7/25/2005 - Mylan Announces Tentative Approval for Ondansetron Hydrochloride Tablets |
| 10/25/2005 - Icahn Drops Mylan Litigation for the Second Time |
| 12/25/2005 - 05 Mylan Laboratories Announces Final Results of its Modified
'Dutch Auction' Self Tender Offer and Closing of Related Financing |
| 10/25/2005 - Mylan Updates Status on Topiramate Summary Judgment Motion |